Q4 2023 Holdings
Filed 2024-02-15 | 425 holdings | $157.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $96.2K | 2,705 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $96.5K | 16,894 | 0.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $96.5K | 11,222 | 0.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $96.7K | 6,289 | 0.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $96.9K | 4,148 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $96.9K | 1,605 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $97.6K | 12,008 | 0.1% |
| Ambrx Biopharma Inc | CO | 641871108 | $97.9K | 6,878 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $98.1K | 3,274 | 0.1% |
| Precigen Inc(PGEN) | COM | 74017N105 | $98.5K | 73,477 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $98.8K | 796 | 0.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $99.0K | 15,962 | 0.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $99.2K | 3,243 | 0.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $99.5K | 9,447 | 0.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $100.0K | 5,521 | 0.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $100.2K | 1,805 | 0.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $100.2K | 2,490 | 0.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $100.3K | 5,251 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $100.6K | 11,931 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $100.6K | 15,692 | 0.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $100.6K | 4,657 | 0.1% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $100.7K | 121,626 | 0.1% |
| Merus N V | COM | N5749R100 | $100.7K | 3,662 | 0.1% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $101.0K | 4,278 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $101.5K | 3,540 | 0.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $101.6K | 2,561 | 0.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $102.2K | 4,457 | 0.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $102.3K | 4,507 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $102.3K | 9,295 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $103.4K | 2,245 | 0.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $104.1K | 3,302 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $104.1K | 4,862 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $104.2K | 7,833 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $104.3K | 4,787 | 0.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $104.3K | 11,529 | 0.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $104.5K | 7,019 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $104.9K | 11,992 | 0.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $105.2K | 2,459 | 0.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $105.4K | 7,515 | 0.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $106.6K | 10,264 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $106.8K | 2,595 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $106.9K | 10,356 | 0.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $107.9K | 6,328 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $109.1K | 2,743 | 0.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $109.7K | 34,163 | 0.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $109.8K | 18,666 | 0.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $110.9K | 10,879 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $111.3K | 3,984 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $111.4K | 7,747 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $111.6K | 6,172 | 0.1% |